Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 20, 2010
[Meta Analysis of Association between Polymorphisms in Promoter Region of MMPs gene and Risk of Lung Cancer.]Zhe Lei, Rengyun Liu, Jun Chen, et al.Journal of the National Cancer Institute|December 19, 2023
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressivenessRengyun Liu, Guangwu Zhu, Jie Tan, et al.Proceedings of the National Academy of Sciences of the United States of America|June 21, 2020
<i>TERT</i> promoter mutation determines apoptotic and therapeutic responses of <i>BRAF</i>-mutant cancers to BRAF and MEK inhibitors: Achilles HeelJie Tan, Rengyun Liu, Guangwu Zhu, et al.Endocrine|February 15, 2024
Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancerYe Sang, Guanghui Hu, Junyu Xue, et al.The Journal of Clinical Endocrinology and Metabolism|May 23, 2019
Stage II Differentiated Thyroid Cancer Is a High-Risk Disease in Patients <45/55 Years OldZeming Liu, Xiaopei Shen, Rengyun Liu, et al.Oncotarget|November 19, 2016
Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressivenessTao Zhang, Xiaopei Shen, Rengyun Liu, et al.Molecular Oncology|July 20, 2024
The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K-AKT pathwayXiaopei Shen, Jie Tan, Rengyun Liu, et al.Frontiers in Oncology|February 5, 2024
<i>TERT</i> promoter methylation is associated with high expression of TERT and poor prognosis in papillary thyroid cancerShiyong Li, Junyu Xue, Ke Jiang, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 4, 2010
[Defective expression of TGFBR3 gene and its molecular mechanisms in non-small cell lung cancer cell lines]Xiefang Jiang, Rengyun Liu, Zhe Lei, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 4, 2019
The Genetic Duet of <i>BRAF</i> V600E and <i>TERT</i> Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid CancerJiajun Liu, Rengyun Liu, Xiaopei Shen, et al.Pageof 6